BSE filing, NSE: RIBATEX. Summary written from the filing by ALFA Finder's alert engine.
Riba Textiles Ltd: key numbers
- Share price
- ₹62.90
- Market cap
- ₹60.72 Cr
- Revenue (annual)
- ₹255.4 Cr
- Net profit (annual)
- ₹8.13 Cr
- P/E (TTM)
- 7.7×Sector 49.5×
- Promoter holding
- 62.15%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Riba Textiles Ltd
All →Riba Textiles Annual General Meeting
Riba Textiles' 38th AGM adopted FY26 audited financials and re-appointed key directors. Routine governance outcomes with no material capital or operational decisions.
Riba Textiles Annual Report
Riba Textiles Ltd has submitted its 38th Annual Report and Notice of AGM for the financial year 2025-26, as per SEBI listing regulations.
Riba Textiles Annual General Meeting
Riba Textiles Limited scheduled its 38th Annual General Meeting for September 24, 2026. The meeting will be conducted via video conference with remote e-voting facility.
Riba Textiles Management Change
Riba Textiles Ltd announced the re-appointment of Shyam Sunder Miglani, Amit Garg, and Nitin Garg as Directors for fresh terms, as approved by the Board.
Riba Textiles Board Meeting Outcome
Riba Textiles Ltd announced the outcome of its board meeting, including the approval of the Annual Report and the re-appointment of key managerial personnel. The company scheduled its 38th Annual General Meeting for September 24, 2026.
Riba Textiles Credit Rating
CARE Ratings reaffirmed Riba Textiles Limited's 'CARE BBB; Stable' and 'CARE A3+' ratings for bank facilities totaling ₹94 Crore. The rating reflects the company's established export market presence.
- Value
- ₹94.00 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.